Kibow Biotech, Inc. Marks Its Continued Growth with Relocation to Larger Facilities
8/1/2012 10:42:17 AM
More...
|
Kibow Biotech, Inc. Showcases RENADYL(TM) at Biotechnology Industry Organization (BIO) 2012 Conference, Boston, MA
6/18/2012 11:59:33 AM
More...
|
Kibow Biotech, Inc. Release: Interim Clinical Trial Results Confirm Safety of Renadyl(TM), a Probiotic Dietary Supplement for the Support of Healthy Kidney Function
3/8/2012 11:42:18 AM
More...
|
Kibow Biotech, Inc. Changes Name of Flagship Kidney Function Support Product to "RENADYL(TM)"
11/8/2011 1:54:31 PM
More...
|
Kibow Biotech, Inc. Secures $2.4 Million Towards Its Human Clinical Trials by Continued Veterinary Licensing Agreement
8/25/2011 11:03:27 AM
More...
|
Institutional Review Board Approval Obtained for Study of Kibow Biotech, Inc.'s Biotics in Dialysis Patients with End-stage Chronic Kidney Disease
3/10/2011 7:44:00 AM
More...
|
Kibow Biotech, Inc. Releases Results of Pilot Scale Study of Its Probiotic Formulation for Kidney Health
10/4/2010 7:39:53 AM
More...
|
Kibow Biotech, Inc. Selected to Present at the China Bio Partnering Forum 2010
6/22/2010 11:16:44 AM
More...
|
Kibow Biotech, Inc. to Present at Biotechnology Industry Organization (BIO) 2009 International Convention: Innovations to Heal, Fuel, and Feed the World
5/14/2009 8:28:06 AM
More...
|
Kibow Biotech, Inc. and Vétoquinol S.A. Expand Their Veterinary Licensing and Marketing Agreement for Worldwide Applications
2/25/2008 8:53:13 AM
More...
|
|